Overview

Study to Evaluate the Safety and Efficacy of GABITRIL Treatment in Adults With Generalized Anxiety Disorder.

Status:
Completed
Trial end date:
2006-12-01
Target enrollment:
Participant gender:
Summary
A 12-Month, Open-Label, Flexible-Dosage Study to Evaluate the Safety and Efficacy of GABITRIL Treatment in Adults with Generalized Anxiety Disorder.
Phase:
Phase 3
Details
Lead Sponsor:
Cephalon
Treatments:
Tiagabine